R-METHUSCF AND FILGRASTAM IN HIGH-GRADE NON-HODGKIN'S LYMPHOMA

R-METHUSCF 和 FILGRASTAM 治疗高级别非霍奇金淋巴瘤

• 批准号: 3743157
• 负责人: MICHAEL S GORDON
• 金额: --
• 依托单位: INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3743157
• 关键词: clinical trials; colony stimulating factor; drug screening /evaluation; hematopoietic growth factor; hematopoietic stem cells; human subject; human therapy evaluation; neoplasm /cancer chemotherapy; nonHodgkin's lymphoma; recombinant proteins

This is a phase I trial of Peripheral Blood Progenitor Cells mobilized by Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF) and Filgrastim (r-metHuG-CSF) in patients with intermediate or immunoblastic high-grade Non-Hodgkin's Lymphoma.

这是一项动员外周血祖细胞的I期试验 通过重组甲硫氨酰人干细胞因子（r-metHuSCF）和 非格司亭（r-metHuG-CSF）治疗中间型或免疫母细胞性 高度非霍奇金淋巴瘤